Bempedoic acid becomes the first ATP citrate lyase inhibitor and first oral non-statin to meet the major adverse cardiovascular events (MACE-4) primary endpoint
December 08, 2022
Esperion Announces CLEAR Cardiovascular Outcomes Trial of NEXLETOL (bempedoic acid) Meets Primary Endpoint
December 8, 2022 — Esperion announced that the landmark Cholesterol Lowering via Bempedoic acid, an ACL-Inhibiting …
Read More
Jonathan Rothberg, PhD
December 08, 2022
Butterfly Announces CEO Transition
December 8, 2022 — Butterfly Network, Inc., a digital health company transforming care with handheld, whole-body…
Read More
Brian Arends, left, checks the electrical resistivity and conductivity of the wearable heart monitor as Zheng Yan, center, and Yadong Xu, right, observe in Yan's lab. The lab is located in the Roy Blunt NextGen Precision Health building. Pate McCuien/University of Missouri
December 07, 2022
University of Missouri Researchers Design New Heart Health Wearable
December 7, 2022 —  While heart disease is a leading cause of death in the United States, most people can be treated…
Read More
December 07, 2022
Computerized Decision Support System Helps to Reduce Cardiovascular Risk Factors in Patients with Diabetes
December 7, 2022 —  Compared with team-based care alone, the addition of a computerized clinical decision support…
Read More
Allogeneic CardiALLO therapy for heart failure to complement autologous cell therapy currently enrolling in Phase III CardiAMP Heart Failure clinical trial
December 07, 2022
BioCardia Announces FDA Approval of IND Application for Allogeneic NK1R+ Human Mesenchymal Stem Cells for Ischemic Heart Failure
December 7, 2022 —   BioCardia, Inc., a developer of cellular and cell-derived therapeutics for the treatment of…
Read More
December 07, 2022
Ultromics Receives FDA Clearance for AI-based Platform for Echocardiography
December 7, 2022 — Ultromics has announced that its EchoGo Heart Failure, an artificial intelligence (AI) platform for…
Read More
Designed to assist physicians detect findings on chest X-rays suggestive of Aortic Atherosclerosis and Aortic Ectasia.
December 05, 2022
Imagen Technologies Announces FDA Clearance of Aorta-CAD
December 5, 2022 —  Imagen Technologies, Inc. announced the U.S. Food and Drug Administration's 510(k) clearance of the…
Read More
The U.S. Food and Drug Administration (FDA) is alerting health care facilities and providers of a shortage of Getinge Maquet/Datascope Intra-Aortic Balloon Pump (IABP) devices,
December 05, 2022
Getinge Maquet/Datascope Intra-Aortic Balloon Pump (IABP) Shortage - Letter to Health Care Providers
December 5, 2022 —  The U.S. Food and Drug Administration (FDA) is alerting health care facilities and providers of a…
Read More
December 05, 2022
Top 10 Most-read Content in November
Here is a recap of what DAIC viewers found most interesting during the month of November: 1. Study Finds That Risk of…
Read More
Ms. Nieves, donor family, and doctors. Photo courtesy of Montefiore Health System.
December 02, 2022
World's First HIV-Positive to HIV-Positive Heart Transplant Recipient Meets Donor Family, Shares Gratitude for Life & Advocates for Organ Donation
December 2, 2022 —  Westchester resident, 62-year-old Miriam Nieves, is especially grateful this Thanksgiving season.…
Read More
Boston Scientific Corporation has announced the first results from the ACURATE neo2 Post Market Clinical Follow-up (PMCF) study evaluating the performance of the ACURATE neo2TM Aortic Valve System.
December 02, 2022
Late-Breaking Post-Market Study Data Reinforce Clinical Procedural Success and Safety of the ACURATE neo2 Aortic Valve System
December 2, 2022 —  Boston Scientific Corporation has announced the first results from the ACURATE neo2 Post Market…
Read More
Last year, U.S. Congressman Andy Barr (KY-06) introduced this legislation in the House to honor the legacy of his wife, Carol Leavell Barr, who passed away tragically from sudden cardiac death brought on by mitral valve prolapse, an underlying heart condition that causes death in .2% of cases.
December 02, 2022
CAROL Act Will Prioritize Research on Heart Valve Disease
December 2, 2022 —  The U.S. Senate today passed the bipartisan Cardiovascular Advances in Research and Opportunities…
Read More
Transverse heart sections from wild type mice (WT) and transgenic mice overexpressing beta-3 adrenergic receptor in cardiomyocytes (c-hB3tg) after 3 months of aortic stenosis (transaortic constriction, TAC) or control (sham). Hypertrophy after TAC was less severe in the transgenic mice. Courtesy of CNIC
December 01, 2022
A New Therapeutic Target for the Prevention of Heart Failure Due to Aortic Stenosis
December 1, 2022 —  Scientists at the Centro Nacional de Investigaciones Cardiovasculares (CNIC) have identified a new…
Read More
Annalise.ai and Nuance announced that the global medical imaging AI company has joined the Nuance Precision Imaging Network (PIN), connecting Annalise.ai workflow orchestration and diagnostic support solutions to over 12,000 healthcare facilities worldwide.
December 01, 2022
HeartSciences and Rutgers University Announce Multi-Year Collaboration to Develop AI-based ECG Algorithms
December 1, 2022 —  Heart Test Laboratories, Inc. d/b/a HeartSciences, a medical technology company focused on saving…
Read More
A team led by UTHealth Houston's K. Lance Gould, MD, (center) used PET imaging technology (shown above) to map coronary blood flow and its outcomes among heart disease patients. (Photo by UTHealth Houston)
December 01, 2022
PET Technology More Effective Than Angiogram at Determining Need for Coronary Stents, Bypass Surgery
December 1, 2022 —  A new method for determining whether patients with heart disease need coronary stents or bypass…
Read More
November 30, 2022
Cardiothoracic Surgeon to Lead Smidt Heart Institute's ECMO Program
November 30, 2022 — The Smidt Heart Institute at Cedars-Sinai has selected board-certified cardiothoracic surgeon Tyler…
Read More
Boston Scientific Corporation has announced the first results from the ACURATE neo2 Post Market Clinical Follow-up (PMCF) study evaluating the performance of the ACURATE neo2TM Aortic Valve System.
November 30, 2022
Late-Breaking Post-Market Study Data Reinforce Clinical Procedural Success and Safety of the ACURATE neo2 Aortic Valve System
November 30, 2022 — Boston Scientific Corporation has announced the first results from the ACURATE neo2 Post Market…
Read More
Boston Scientific Corporation has announced the first results from the ACURATE neo2 Post Market Clinical Follow-up (PMCF) study evaluating the performance of the ACURATE neo2TM Aortic Valve System.
November 30, 2022
Medtronic’s Next-Gen Evolut FX TAVR System Shows Significant Improvement in Commissure Alignment in Real World Setting
November 30, 2022 — Medtronic’s newest generation self-expanding, transcatheter aortic valve replacement (TAVR) system…
Read More
Figure 1. Normal chest X-ray
November 29, 2022
AI Predicts Heart Disease Risk Using Single X-Ray
November 29, 2022 — Researchers have developed a deep learning model that uses a single chest X-ray to predict the 10-…
Read More
Tanya Therapeutics announced today that the US FDA has granted orphan drug designation for its second gene therapy product candidate, TN-401, for the treatment of arrhythmogenic right ventricular cardiomyopathy (ARVC)
November 28, 2022
Tenaya Therapeutics Receives Orphan Drug Designation from the U.S. Food and Drug Administration for its Gene Therapy for Genetic Arrhythmogenic Right Ventricular Cardiomyopathy
November 28, 2022 – Tenaya Therapeutics, a clinical-stage biotechnology company with a mission to discover, develop and…
Read More
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now